Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 5Phase 3 2Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2NETWORK 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Incontinence 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Pain 1Neurotoxicity Syndromes 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Duloxetine Hydrochloride × Clear all
NCT00489411 2017-04-26

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
231 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

NCT02367404 2016-09-13

Prospective RCT on Post Prostatectomy Urine Leak

Institut Mutualiste Montsouris

Phase 3 Unknown
240 enrolled
Genitourinary

Prostatic Neoplasms, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡